Showing results (41-50 of 199) with videos related to
Sort By:
Pageof 20
Trends in Immunology|August 24, 2017
cGAS-STING and Cancer: Dichotomous Roles in Tumor Immunity and DevelopmentKevin W Ng, Erin A Marshall, John C Bell, et al.Current Pharmaceutical Biotechnology|July 12, 2011
Targeted and armed oncolytic poxviruses for cancer: the lead example of JX-594Caroline J Breitbach, Steve H Thorne, John C Bell, et al.Trends in Molecular Medicine|May 4, 2004
Vesicular stomatitis virus: re-inventing the bulletBrian D Lichty, Anthony T Power, David F Stojdl, et al.Expert Opinion on Biological Therapy|August 13, 2008
Development of targeted oncolytic virotherapeutics through translational researchTa-Chiang Liu, Tae-Ho Hwang, John C Bell, et al.Nature Reviews. Cancer|July 4, 2014
Going viral with cancer immunotherapyBrian D Lichty, Caroline J Breitbach, David F Stojdl, et al.Plos Pathogens|January 24, 2014
From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancerCarolina S Ilkow, Stephanie L Swift, John C Bell, et al.Journal of Visualized Experiments : Jove|July 7, 2011
Ex vivo infection of live tissue with oncolytic virusesJean-Simon Diallo, Dominic Roy, Hesham Abdelbary, et al.Cytokine & Growth Factor Reviews|May 18, 2010
Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: no shortcuts on the road to approvalCaroline J Breitbach, Tony Reid, James Burke, et al.Journal of Virology|September 7, 2012
Relationship between within-host fitness and virulence in the vesicular stomatitis virus: correlation with partial decouplingVictoria Furió, Raquel Garijo, María Durán, et al.Frontiers in Genetics|September 25, 2013
Exploiting tumor epigenetics to improve oncolytic virotherapyNicole E Forbes, Hesham Abdelbary, Mathieu Lupien, et al.Pageof 20